William H. Frey II, PhD

Professor
Department of Neurology, Pharmaceutics, and Oral Biology

University of Minnesota

Dr. William H. Frey II is the Founder and Co-Director of the Alzheimer's Research Center at Regions Hospital, Professor of Pharmaceutics and faculty member in Neurology, Oral Biology and Neuroscience at the University of Minnesota and consultant to the pharmaceutical and biotechnology industry. The intranasal insulin treatment he developed for Alzheimer’s disease has been shown in multiple clinical trials to improve memory in both Alzheimer’s patients and normal adults. The intranasal therapeutic (stem) cell treatment he discovered has been shown to bypass the blood-brain barrier to treat Parkinson's, stroke, neonatal ischemia, multiple sclerosis and subarachnoid hemorrhage in animal models of these disorders.

Read a recent Neurology Reviews cover story written by their editor entitled: Intranasal Drug Delivery Bypasses the Blood-Brain Barrier which describes intranasal treatments based on Dr. Frey's discoveries using drugs, peptides, biologics and therapeutic stem cells for Alzheimer's, Parkinson's, MS, brain tumors, stroke, traumatic brain injury and other brain disorders: PDF icon Click Here

Event date: 
Wednesday, October 19, 2016 -
10:30am to 11:30am
Event location: 

2-520 Moos Tower